Terms: = Lung cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Clinical Outcome
5 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment.
Messaritakis I; Nikolaou M; Koinis F; Politaki E; Koutsopoulos A; Lagoudaki E; Vetsika EK; Georgoulias V; Kotsakis A
Lung Cancer; 2019 Sep; 135():33-39. PubMed ID: 31447000
[TBL] [Abstract] [Full Text] [Related]
3. Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment.
Messaritakis I; Nikolaou M; Politaki E; Koinis F; Lagoudaki E; Koutsopoulos A; Georgoulia N; Georgoulias V; Kotsakis A
Lung Cancer; 2018 Oct; 124():270-278. PubMed ID: 30268472
[TBL] [Abstract] [Full Text] [Related]
4. clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.
Ilie M; Long E; Hofman V; Selva E; Bonnetaud C; Boyer J; Vénissac N; Sanfiorenzo C; Ferrua B; Marquette CH; Mouroux J; Hofman P
Br J Cancer; 2014 Mar; 110(5):1236-43. PubMed ID: 24473396
[TBL] [Abstract] [Full Text] [Related]
5. [A clinicopathological study of clear cell sarcoma of the kidney].
He L; Fu L; Wang L; Li P; Lang Z
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):422-5. PubMed ID: 11866983
[TBL] [Abstract] [Full Text] [Related]
